Evidence map›Paper›PMID 24328819›Full record

ReviewAntioxidants & redox signaling2014

Exploiting oxidative microenvironments in the body as triggers for drug delivery systems.

Shivanjali Joshi-Barr, Caroline de Gracia Lux, Enas Mahmoud, Adah Almutairi

Abstract readReview
In one paragraph

Review in Antioxidants & redox signaling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. [ZIF-8@Pt Nanozyme Used for Scavenging Reactive Oxygen Species in the Treatment of Rheumatoid Arthritis].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Oxidative Degradation of Sequence-Defined Peptoid Oligomers.Molecular systems design & engineering · 2023
    Article
  12. Article
  13. An update on microneedle-based systems for diabetes.Drug delivery and translational research · 2022
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shivanjali Joshi-Barr1 Skaggs School of Pharmacy and Pharmaceutical Sciences, Laboratory of Bioresponsive Materials, University of California , San Diego, San Diego, California.
Caroline de Gracia Lux
Enas Mahmoud
Adah Almutairi
University of California System · US

Funding

Chemically amplified response strategies for medical sciences; concepts borrowedDP2OD006499 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALMUTAIRI, ADAH · 2009 to 2009
$2.3M
NIH HHS DP2OD006499
6 · The paper itself

Abstract

significanceReactive oxygen species and reactive nitrogen species (ROS/RNS) play an important role in cell signaling pathways. However, the increased production of these species may disrupt cellular homeostasis, giving rise to pathological conditions. Biomaterials that are responsive to ROS/RNS can be strategically used to specifically release therapeutics and diagnostic agents to regions undergoing oxidative stress. RECENT ADVANCES: Many nanocarriers intended to exploit redox micro-environments as triggers for drug release, summarized and compared in this review, have recently been developed. We describe these carriers' chemical structures, strategies for payload protection and oxidation-selective release, and ROS/RNS sensitivity as tested in initial studies. CRITICAL ISSUES: ROS/RNS are unstable, so reliable measures of their concentrations in various conditions are scarce. Combined with the dearth of materials shown to respond to physiologically relevant levels of ROS/RNS, evaluations of their true sensitivity are difficult. FUTURE DIRECTIONS: Oxidation-responsive nanocarriers developed thus far show tremendous potential for applicability in vivo; however, the sensitivity of these chemistries needs to be fine tuned to enable responses to physiological levels of ROS and RNS.

Indexed as

Oxidative StressAnimalsDrug CarriersDrug Delivery SystemsHumansNanostructuresOxidation-ReductionReactive Nitrogen SpeciesReactive Oxygen SpeciesSignal TransductionDrug CarriersReactive Nitrogen SpeciesReactive Oxygen Species

Identifiers

PMID24328819
PMCPMC4098119
OpenAlexW2324033578

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.